IP Library Granted Patent US 9,261,513
Granted Patent B1
US 9,261,513 · App. 14/330,209 · Granted Feb 16, 2016

Antibody biomarker specific for mitotic cells and related methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,261,513
App. No.
14/330,209
Granted
Feb 16, 2016
Kind
B1
Abstract

An isolated antibody having a specific binding affinity for a polypeptide comprising the amino acid sequence HTEGKP (SEQ ID NO: 2) phosphorylated at threonine is described. The antibody may be used as biomarker for mitotic cells. A method for using the antibody includes contacting a cell with the antibody and detecting antibody bound to the cell as an indicator of the cell being in the mitotic state. A reagent kit comprising the antibody is also described.

Claims (12)

1. A method of immunostaining at least one mitotic cell, the method comprising contacting the at least one mitotic cell with an antibody having specific binding affinity for a cellular marker indicative of the mitotic state, the marker comprising SEQ ID NO: 2 phosphorylated at threonine, wherein the antibody has no specific binding affinity for SEQ ID NO: 2 when SEQ ID NO: 2 is not phosphorylated at threonine.

2. The method of claim 1 , wherein the antibody is generated with a peptide consisting of SEQ ID NO: 2 phosphorylated at threonine.

3. The method of claim 1 , wherein the antibody is polyclonal.

4. The method of claim 1 , wherein the cells are mammalian.

5. The method of claim 1 , further comprising staining the at least one cell with a secondary antibody.

6. The method of claim 5 , wherein the secondary antibody comprises a fluorophore.

7. A reagent kit comprising an antibody having specific binding affinity for an amino acid sequence comprising SEQ ID NO: 2 phosphorylated at threonine, the antibody having no specific binding affinity for SEQ ID NO: 2 when SEQ ID NO: 2 is not phosphorylated at threonine.

8. The kit of claim 7 , wherein the antibody is polyclonal.

9. The kit of claim 7 , wherein the antibody is generated with a peptide consisting of SEQ ID NO: 2 phosphorylated at threonine.

10. An isolated antibody that has a specific binding affinity for a polypeptide comprising SEQ ID NO: 2 phosphorylated at threonine and has no specific binding affinity for SEQ ID NO: 2 when SEQ ID NO: 2 is not phosphorylated at threonine.

11. The isolated antibody of claim 10 , wherein the antibody is polyclonal.

12. The isolated antibody of claim 10 , wherein the antibody is generated with a peptide consisting of SEQ ID NO: 2 phosphorylated at threonine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2015
From: HURT, MYRA; RIZKALLAH, RAED
To: FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Reel/Frame 034820/0967 →